Top Markets
Coin of the day
Bright Minds Biosciences Inc. Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

DRUG
Classificação em ações #11319
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics... Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Preço da ação
$73.12
Última sincronização: 2026-08-28
Valor de mercado
$715.61M
Variação (1 dia)
-1.90%
Variação (1 ano)
88.01%
País
US
Negociar Bright Minds Biosciences Inc. (DRUG)

Categoria

Histórico de preços das ações de Bright Minds Biosciences Inc. (DRUG)
Preço de fecho mais alto: $78.82 em 2026-08-01

Preço de fecho mais baixo: $26.78 em 2021-03-01
Histórico de preços das ações da Bright Minds Biosciences Inc. de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -9.92%
2025 104.69%
2024 2,591.40%
2023 -68.68%
2022 -73.75%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH